Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MLN977: MLNM and partner Taisho Pharmaceutical Co. Ltd. (Tokyo, Japan) discontinued development of MLN977 after elevated liver enzymes were observed in 3 patien

Millennium Pharmaceuticals Inc. (MLNM), Cambridge, Mass.
Product: MLN977 (formerly LDP-977)
Business:

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE